LENSAR Inc (LNSR) vs Telomir Pharmaceuticals, Inc. Common Stock (TELO)

A side-by-side comparison of LENSAR Inc and Telomir Pharmaceuticals, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LNSR vs TELO

growth of $100 · dividends reinvested · last 3y
LNSR +56.9% (+16.2%/yr)TELO -82.7% (-44.3%/yr)LNSR compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020252026$157$17
LNSR TELO

LNSR vs TELO: by the numbers

  • •TELO is the larger company ($83M vs $82M market cap).
  • •LNSR is profitable (57.57% net margin) while TELO runs a net loss (0.00%).

Metrics side by side

Valuation

MetricLNSRTELO
P/S ratio1.37N/A
P/B ratio5.5216.40

Profitability

MetricLNSRTELO
Gross margin47.96%0.00%
Operating margin-42.06%0.00%
Net margin57.57%0.00%
ROE232.78%-116.74%
ROIC-16.28%-120.93%

Growth (annualized)

MetricLNSRTELO
Revenue CAGR (5Y)14.67%N/A
Total return CAGR (5Y)-3.18%N/A

Frequently asked

Is LNSR or TELO more profitable?
LNSR runs the higher net margin — LNSR at 57.57% versus TELO at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.